encouraging to see Calimmune thinking through logistics of a HIV cure, should they ever need to roll one out globallyhttps://promo.gelifesciences.com/gl/K14054/misc/K14054-Xuri-GRC-Brochure.pdf
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%